| Literature DB >> 12788852 |
Naru Babaya1, Hiroshi Ikegami, Tomomi Fujisawa, Koji Nojima, Michiko Itoi-Babaya, Kaori Inoue, Jun Nakura, Michiko Abe, Miyuki Yamamoto, Jin Ji Jin, Zhihong Wu, Tetsuro Miki, Masakatsu Fukuda, Toshio Ogihara.
Abstract
The serum level of high-density lipoprotein cholesterol (HDL-c), which protects against the development of atherosclerosis, is under genetic control. However, the genetic components responsible for the serum HDL-c level are yet to be determined. A recent knockout mouse study demonstrated that hepatocyte nuclear factor-1 alpha (HNF-1 alpha) is an essential transcriptional regulator of HDL-c metabolism. In this study, the association of an HNF-1 alpha gene polymorphism, isoleucine (Ile) 27 leucine (Leu), with lipid parameters, in particular with serum HDL-c level, was studied in 356 unrelated Japanese men. Though no significant difference was observed in total cholesterol and triglyceride levels among the three genotypes, the serum HDL-c level was significantly associated with the genotype (P < 0.01, trend test). Subjects with the Ile/Ile genotype had low serum HDL-c levels, and those with the Leu/Leu genotype had high serum HDL-c levels. These results demonstrate that the HNF-1 alpha gene locus is associated with serum HDL-c level and suggest that the Ile27 allele is a risk marker for atherosclerosis.Entities:
Mesh:
Substances:
Year: 2003 PMID: 12788852 DOI: 10.1210/jc.2002-021891
Source DB: PubMed Journal: J Clin Endocrinol Metab ISSN: 0021-972X Impact factor: 5.958